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Summary.-High-affinity rosette-forming T-cell assays were performed by incuba-
tion of peripheral-blood mononuclear cells with sheep erythrocytes (E) at 29°C. As
compared with normal controls, the levels of high-affinity rosette-forming cells
(RFC) were much more frequently depressed in cancer patients than were the total
E-RFC incubated at 4°C. Only 2/83 normal controls had less than 38% 29°C E-RFC
(mean 48± 5), whilst 78/89 cancer patients were below this level. The few post-
operative patients tested exhibited a normal range of 29°C E-RFC.
The 29°C E-rosette assay gives reproducible counts of a T-cell subset, and is a
sensitive assay for evaluating the immune status of cancer patients.
HUMAN thymus-derived lymphocytes,
or T cells, have been shown to be the
principal effectors of cellular immunity.
Estimates of circulating T cells, as mea-
sured by rosette formation with sheep
erythrocytes, (SRBC), suggest that
changes in the percentage of rosette-
forming cells (E-RFC) may be a reliable
index of the level of immuno-competence
of the host. However, there are a number
of conflicting reports on the proportion
of E-RFC in cancer patients. Some
authors (Stjernsward et al., 1972; Nemoto
et al., 1974) have reported a normal
proportion of T cells in breast-cancer
patients, while others described depressed
E-RFC in similar patients (Keller et al.,
1976; Whitehead et al., 1976; Moroz et al.,
1977; Whitehead et al., 1978) and in
other malignant diseases (Catalona et al.,
1974; Gross et al., 1975).
Other studies have suggested that
modification of the rosette technique with
suboptimal rosetting conditions apparent-
ly permitted better discrimination be-
tween normal individuals and cancer
patients. Therefore, procedures for detect-
ing a subpopulation of the total E-RFC,
termed "active" T-RFC, have been des-
cribed (Wybran & Fudenberg, 1973; Smith
et al., 1975). Wybran & Fudenberg (1973)
foundthatTlymphocytesforming "active"
rosettes were diminished in patients with
various neoplasms, whereas the total num-
ber ofT cells wasfrequentlynormalinsuch
patients. Recently, West et al. (1976) and
Weese et al. (1977) have found that, with
the suboptimal temperature 2900, a "high-
affinity" rosette-formingT-cell assay (2900
E-RFC) was useful in distinguishing be-
tween normal individuals and those with
cancer and certain other diseases.
The present study was carried out to
evaluate the proportion of "high-affinity"
E-RFC and 40C E-RFC in the peri-
pheral blood of cancer patients. We
confirmed the findings ofWest et al. (1976)
that a decrease in 29°C E-RFC was
observed in cancer patients, whereas the
level of 4°C E-RFC did not change.
2900 E-RFC assay is much more sensitive,
and the level of high-affinity rosette-
forming cells reflects better the immune
status of cancer patients.HIGH-AFFINITY ROSETTE ASSAY
MATERIALS AND METHODS
Cancer patients.-This group consisted of
89 patients, among them 5 in the postopera-
tive period: 37 (22 male, 15 female, 29-88
years old), had histologically proven colorec-
tal cancer, and ofthese 4 were postoperative;
12 patients (aged 34-68) had breast cancer;
the blood samples for assay of these patients
were taken at least 3 weeks after chemo-
therapy and irradiation treatment; and 40
patients (25-65 years old) had various
cancers (lung, ovary, stomach, pancreas).
One sample was obtained after removal of
the tumour.
Control groups.-The 83 healthy controls
were mainly laboratory personnel and blood
donors, 18-60 years old.
For further comparison, 35 hospital pati-
ents, 17-73 years old, with various non-
cancerous diseases (biliary lithiasis, sig-
moiditis, chronic ulcerative colitis, Crohn's
disease, alcoholic cirrhosis and one case of
familial colonic polyposis) were included.
Lymphocyte separation.-Ten to 25 ml of
heparinized (20 i.u./ml) blood were diluted
with Eagle's minimum essential medium
(MEM) to 50 ml. The diluted blood was
centrifuged on a layer of Ficoll-Triosil
(density 1-078) for 15 min at 20°C with 900 g
at the interface. The layers rich in mono-
nuclear cell were harvested, pooled and
centrifuged at 500 g for 10 min at 20°C. The
lymphocytes were then washed twice with
MEM and the final pellet was resuspended
at 5 X 106/ml in RPMI 1640 medium
(Eurobio) supplemented with 2 mm gluta-
mine (Grand Island Biological Co., Grand
Island, N.Y.), penicillin (100 u/ml) and
streptomycin (100,ug/ml). Cell counting was
performed with a haemacytometer using
trypan blue in 3% acetic acid solution. This
stain provides excellent definition of nuclear
and cytoplasmic characteristics. Only those
cells with a small round nucleus and relative
paucity of cytoplasm were included in the
cell counts. The above procedure resulted in
alymphocyte suspension consisting of > 97%
mononuclear cells.
Preparation of SRBC.-Sheep blood was
obtained fresh each week from the same
sheep and stored at 4°C in Alsever's solution
(1: 1) and used within 7-10 days. Before use,
SRBC were washed 3 times with MEM and
adjusted to a 0-5% suspension in RPMI 1640.
Human AB 8erum.-Heat-inactivated AB
serum was absorbed against SRBC (v/v) at
20TC for 1 h and 4TC for 30 min before use
in the assay.
E-rosette techniques
Total or 4°C E-RFC.-Quantified by a
minor modification of the method of' West
et al. (1976). Briefly, 0-1 ml of lymphocytes
(5 x 106/ml) was mixed well with 0-1 ml of
AB serum and 041 ml of SRBC (0-5%o) at a
a final SRBC: PBL ratio of 40: 1. Tubes were
incubated at 37TC for 5 min, centrifuged at
200 g for 5 min and the resulting pellet was
incubated at 4TC overnight.
High-affinity or 29°C E-RFC.-This dif-
fered from the total E-RFC assay mainly in
that the overnight incubation at 4TC was
replaced by incubation at 29TC in a water-
bath for 1 h.
E-rosette-forming lymphocytes were quan-
tified in both assays after gentle resuspension
of the cell pellets: one from of the suspension
was placed on a haemacytometer and the
numberofrosettes (3 ormore SRBC surround-
ing a lymphocyte) was counted. All tests
were performed in duplicate and at least
200 lymphocvtes were counted each time.
RESULTS
40C E-RFC
As shown in Fig. 1, the mean percentage
of 4°C E-RFC in the 83 normal subjects
was 65 + 6 (mean i s.d.). The lower
limit of normal has therefore been defined
as the mean 2 s.d., or 5300. Two
normal subjects had E-RFC level lower
than this. Thirty-five patients with non-
malignant diseases exhibited a mean 4°C
E-RFC level of 63 i 9; only one of them,
afflicted with alcoholic cirrhosis, had a
level lower than 53% (190/). The mean
percentage of 4°C E-RFC of the cancer
group was 60 + 7; 9/89 had a 4°C E-RFC
level below 53%.
29°C E-RFC or high-affinity E-RFC
Figure 2 summarizes all results obtained
when assays were performed at 29°C for
1 h. The mean percentage for the normal
group was 48 ± 5; 4 of these subjects
had levels of high-affinity rosettes below
the normal range (380/). Furthermore,
one normal subject who was followed
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FIG. 1.-Distribution of rosette-forming cells
at 4°C in normal, benign disease and cancer
groups. Means for normal controls ± 2 s.d.
are shown by solid and interrupted horizon-
tal lines.
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FIG. 2. Distribution of rosette-forming cells
at 290C in normal, benign-disease and
cancer groups. Means for normal controls
± 2 s.d. are shown by solid and inter-
rupted lines.
serially for 5 months presented a minimal
variation in 29°C E-RFC values (49, 50,
48, 51, 49). Most of the patients with non-
cancerous conditions gave normal values,
and the mean level of this group was
43 ± 10. The 7 individuals in this group
with low 29°C E-RFC had the following
diagnosis: 4 cases of alcoholic cirrhosis at
the decompensation stage, one of Crohn's
disease (out of 2), one of chronic ulcerative
colitis (out of 7), and one of familial
colonic polyposis.
There was an abnormal depression of
the 29°C E-RFC level in the cancer
group (mean 26 10) and most of the
cancer patients (78/89) had values below
the lower limit ofthe normal range (38%).
In contrast, the 5 samples obtained in
the postoperative period gave values
within the normal 29°C E-RFC.
DISCUSSION
The SRBC rosette constitutes a con-
venient marker for human T lymphocytes
and may reflect their role in immuno-
surveillance. Thus the proportion of cir-
culating rosette-forming cells may serve
as a useful indicator of the immune
status of cancer patients. However, there
is some disparity in studies oftotal E-RFC
in peripheral blood of cancer patients.
Stjernsward et al. (1972) and Nemoto
et al. (1974) found no significant difference
between the levels of E-RFC in breast-
cancer patients and normal controls. By
contrast, both Keller et al. (1976) and
Whitehead et al. (1976) reported that the
percentage was significantly depressed
in breast-cancer patients when compared
with age-matched controls. Recently
Whitehead et al. (1978) have demon-
strated that the discrepancy in the results
for the level of total E-rosette formation
in cancer patients is due to incubation
time. They found that the levels of E-
rosetting cells in both cancer patients and
elderly subjects, found low by the usual
technique, increased significantly and ap-
proached, after overnight incubation at
4°C, the level found in healthy young
subjects.
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In this study we have found that there
is no significant difference with our
technique in 4°C E-RFC values between
normal subjects and cancer patients.
We showed that only 9/89 cancer patients
(10%) had a level of 4°C E-RFC below
the lower normal limit (53%) defined as
the mean value 2 s.d. The high level
of tofal E-RFC in cancer patients in our
studies may be due to the overnight
incubation as demonstrated by White-
head et al. (1978); however, with our
ratio of- SRBC to lymphocytes (40:1),
there is no effect of incubation time at
4°C on rosette formation, according to
Chisholm et at. (1976).
It is reported that the depressed
response to phytohaemagglutinin and in
the MLC of blood lymphocytes in some
cancer patients is due to the presence of
suppressor cells, even though the total
E-RFC is within the normal range (Ber-
linger et al., 1976; Zembala et al., 1977;
Quan & Burtin, 1978). Thus the level of
4°C E-RFC does not always correlate
well with the clinical and immune status
ofpatients with malignant diseases. Other
studies have suggested that a modification
of the rosette technique will allow
measurement of a T-cell subpopulation,
and that a large proportion of cancer
patients can be identified by abnormally
low levels of this T subpopulation.
Wybran & Fudenberg (1973), using the
"active" rosette assay, have demon-
strated a decrease in rosette formation
by PBL of cancer patients, whereas the
majority of these patients had a normal
percentage of total E-RFC.
More recently, on the basis of relative
affinity for SRBC, West et al. (1976) have
reported a 29°C rosette assay (with a
ratio SPBC/PBL at 120/1) as useful in
distinguishing between normal individuals
and those with cancer and certain other
diseases.
Using the same method, but with a
ratio of SRBC/PBL 40/1, we have
demonstrated that patients with malig-
nancies have an abnormally low level of
the subpopulation of T cells which forms
rosettes at elevated temperatures. Our
findings confirmed those of West et al.
(1976) and Jerells et al. (1978). Most
cancer patients show a level of high-
affinity E-RFC below the lower limit of
normal values (38%).
In patients with non-cancerous diseases,
there were 7 with a high-affinity RFC
level below 38%. Of these 7, 4 were at an
advanced stage of alcoholic cirrhosis with
markedly abnormal liver function in-
cluding raised transaminase levels. Of the
3 other patients, one was suffering from
chronic ulcerative colitis, one from Crohn's
disease and one from familial colonic
polyposis. Low levels of 29WC E-RFC in
alcoholic-cirrhosis patients have already
been reported (West et al., 1976). On the
other hand, apart from familial colonic
polyposis, which is considered as a pre-
cancerous condition, it is noteworthy
that chronic ulcerative colitis (Kirsner,
1970) and Crohn's disease (Perret et al.,
1968; Weedon et al., 1973) have been
reported as increasing the risk of cancer
of the large intestine. Yet we do not
know that the low level of 29WC E-RFC
found in our patients afflicted with one of
these diseases is explicable by the presence
of an associated carcinoma. Clinical data
gave no evidence for such an association.
In the cancer group, we observed some
cases with a high level of 29W E-RFC;
5 of these were postoperative patients.
Our findings confirmed those of Weese
et al. (1977), who have reported that
cancer patients with depressed 29WC
E-RFC usually showed a return to
normal within 3 weeks of surgery. The
reproducibility of the technique over time
is demonstrated by the serial studies of
one normal donor who showed minimal
variation in 29W E-RFC.
What is the mechanism responsible
for the depression of high-affinity E-RFC
in patients with malignant diseases?
West et at. (1976) have suggested that an
underlying alteration ofthe T-cell receptor
for SRBC in cancer patients and certain
other diseases resulted in decreased rosette
cohesiveness at raised temperatures. At
609610 P.-C. QUAN AND P. BURTIN
least 2 factors may affect the avidity of
lymphocytes for SRBC: 1-the density of
SRBC receptors on the surface of the
lymphocytes and 2-the affinity of those
receptors for SRBC.
A change in either of these may result
in a change in the percentage of rosette
formation (Chisholm &Tubergen, 1976). At
29TC, there may be a decrease in the
density and/or the affinity of SRBC of
cancer patients' lymphocyte surface, caus-
ing a decline of E-RFC. The way in
which the presence of tumour produces
the drop in high-affinity rosette-forming
cells remains a matter of speculation.
It is not known, either, whether the
decrease of 290C E-RFC precedes the
appearance of the tumour.
We have demonstrated that most cancer
patients have a depressed proportion of
high-affinity E-RFC in their peripheral
blood, contrasting with normal total
T-cell levels. According to West et al.
(1977), the fall of high-affinity E-RFC
correlated with an increase in the number
of low-affinity E-RFC which possess Fc
receptors for IgG and are effector cells
in K (West et al., 1978) and NK activity
(Kay et al., 1977). It will, therefore, be
important to study concomitantly rosette
formation both at 400 and 290C, and
cellular immune functions such as K and
NK activity in cancer patients.
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